Atlas Trials

A Phase II, Randomized Study of ACZONE™ (Dapsone) Gel, 5% for Papulopustular Rosacea.

Clinical trial NCT00249782 · COMPLETED

Trial details

NCT number
NCT00249782
Sponsor
Allergan
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Rosacea
Start date
2005-11-01
Primary completion
2006-05-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.